XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements

4. Fair Value Measurements

The composition of our financial assets and liabilities among the three levels of the fair value hierarchy are as follows (in millions):

 

 

 

March 31, 2022

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

20.0

 

 

$

 

 

$

 

 

$

20.0

 

Foreign certificates of deposit and time deposits

 

 

 

 

 

245.3

 

 

 

 

 

 

245.3

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign certificates of deposit and time deposits

 

 

 

 

 

10.5

 

 

 

 

 

 

10.5

 

Derivative assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Designated hedging derivatives - foreign exchange contracts(1)

 

 

 

 

 

14.8

 

 

 

 

 

 

14.8

 

Total financial assets

 

$

20.0

 

 

$

270.6

 

 

$

 

 

$

290.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-designated hedging derivatives - foreign exchange contracts(1)

 

$

 

 

$

3.8

 

 

$

 

 

$

3.8

 

Contingent consideration

 

 

 

 

 

 

 

 

7.3

 

 

 

7.3

 

Total financial liabilities

 

$

 

 

$

3.8

 

 

$

7.3

 

 

$

11.1

 

 

(1)Designated hedging derivatives are presented net of the non-designated hedging derivatives within other current assets in the Company’s consolidated balance sheet.

 

 

 

 

 

December 31, 2021

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

117.7

 

 

$

 

 

$

 

 

$

117.7

 

Foreign certificates of deposit and time deposits

 

 

 

 

 

216.4

 

 

 

 

 

 

216.4

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

 

 

 

 

112.0

 

 

 

 

 

 

112.0

 

Foreign certificates of deposit and time deposits

 

 

 

 

 

11.3

 

 

 

 

 

 

11.3

 

Mutual funds

 

 

 

 

 

45.7

 

 

 

 

 

 

45.7

 

Derivative assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Designated hedging derivatives - foreign exchange contracts(1)

 

 

 

 

 

9.3

 

 

 

 

 

 

9.3

 

Total financial assets

 

$

117.7

 

 

$

394.7

 

 

$

 

 

$

512.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-designated hedging derivatives - foreign exchange contracts(1)

 

$

 

 

$

2.3

 

 

$

 

 

$

2.3

 

Contingent consideration

 

 

 

 

 

 

 

 

257.6

 

 

 

257.6

 

Total financial liabilities

 

$

 

 

$

2.3

 

 

$

257.6

 

 

$

259.9

 

 

(1) Designated hedging derivatives are presented net of the non-designated hedging derivatives within other current assets in the Company’s consolidated balance sheet.

 

 

The following table presents the activity for the three months ended March 31, 2022 related to our Level 3 contingent consideration liabilities (in millions):

 

Level 3 Liabilities:

Contingent

Consideration

 

Balance as of December 31, 2021

$

257.6

 

Additions

 

 

Fair value adjustments

 

(25.7

)

Payments

 

(224.6

)

Balance as of March 31, 2022

$

7.3

 

 

In February and March 2022, the Company settled the final contingent consideration obligations related to its Rollic and Small Giant acquisitions in the amounts of $40.0 million and $224.6 million, respectively. For the three months ended March 31, 2022, we recognized expense of $0.1 million and a benefit of $17.7 million within research and development expenses in our consolidated statement of operations related to the Rollic and Small Giant contingent consideration, respectively.

As of March 31, 2022, our contingent consideration obligations relate to the consideration payable in connection Rollic’s acquisitions of Creasaur, Zero Sum and Forgerhero (collectively, the “Rollic studio acquisitions”), in October 2021 (Creasaur and Zero Sum) and November 2021 (Forgerhero).

Under the terms of the Rollic studio acquisitions, contingent consideration may be payable based on the achievement of certain future bookings metrics during each annual period following each individual acquisition’s respective acquisition date for a total of three years, with no maximum limit as to the contingent consideration achievable. For these acquisitions, we estimated the acquisition date fair value of the contingent consideration obligations using a discounted cash flow model. The significant unobservable inputs used in estimating these acquisition date fair value measurements were each entity’s projected performance and a risk-adjusted discount rate.

We estimate the fair value of the Rollic studio acquisitions contingent consideration liabilities at each subsequent reporting period using a discounted cash flow model. The table below outlines the significant unobservable inputs used in estimating their fair values as of March 31, 2022, weighted by the relative fair value of each annual period’s obligation to the total obligation (in millions, except percentages): 

 

 

 

 

March 31, 2022

 

 

Range

 

Weighted Average

 

Annual bookings

 

$6.9 - $34.8

 

$25.8

 

Discount rates

 

14.0% - 14.0%

 

14.0%

 

 

 

Changes in the projected performance of the acquired studios could result in a higher or lower contingent consideration obligation in the future.

 

The estimated fair value of the Rollic studio acquisitions contingent consideration obligations decreased from $15.3 million as of December 31, 2021 to $7.3 million as of March 31, 2022, driven by continued refinement of forecasted financial results. For the three months ended March 31, 2022, we recognized a benefit of $8.0 million within research and development expenses in our consolidated statements of operations related to the Rollic studio acquisitions.